Literature DB >> 1868473

p53 gene mutations in Barrett's epithelium and esophageal cancer.

A G Casson1, T Mukhopadhyay, K R Cleary, J Y Ro, B Levin, J A Roth.   

Abstract

Genomic DNA was extracted from archival pathology specimens comprising 10 squamous and 14 adenocarcinomas, including 7 with Barrett's epithelium adjacent to tumor, and corresponding normal esophagus from the resection margin. The polymerase chain reaction was used to amplify selected exons of p53 which were analyzed for mutations using single-strand conformation polymorphism analysis. Mutations were localized to exon 8 for 1 adenocarcinoma and to exon 5 for 1 squamous tumor and 4 of 7 Barrett's specimens. Sequencing confirmed mutations at codons 273 (CGT----CAT; adenocarcinoma) and 176 (TGC----TTC; squamous) and in Barrett's epithelium at codons 152 (CCG----CTG), 155 (ACC----GCC) and 175 (CGC----CAC). Specimens of Barrett's epithelium from separate sites had identical p53 mutations suggesting a clonal origin. Cancers arising in mutant epithelium did not have mutations corresponding to those found in the Barrett's specimens suggesting that other events are required for tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1868473

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

Review 1.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  Molecular biology of Barrett's esophagus and esophageal cancer:role of p53.

Authors:  Alan G Casson
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

Review 3.  [Barrett's esophagus. An update].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

4.  The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis.

Authors:  Siddharth Singh; Manoj Kumar; Sanjeev Kumar; Shrinka Sen; Pawan Upadhyay; Sayan Bhattacharjee; Naveen M; Vivek Singh Tomar; Siddhartha Roy; Amit Dutt; Tapas K Kundu
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

5.  Clinicopathological findings and p53 expression of thyroid cancer in children.

Authors:  T Kobayashi; H Nakanishi; I Yana; I Nishisho; Y Itoh; E Wakasugi; T Takeda; T Mori
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

6.  Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma.

Authors:  Nishant Agrawal; Yuchen Jiao; Chetan Bettegowda; Susan M Hutfless; Yuxuan Wang; Stefan David; Yulan Cheng; William S Twaddell; Nyan L Latt; Eun J Shin; Li-Dong Wang; Liang Wang; Wancai Yang; Victor E Velculescu; Bert Vogelstein; Nickolas Papadopoulos; Kenneth W Kinzler; Stephen J Meltzer
Journal:  Cancer Discov       Date:  2012-08-09       Impact factor: 39.397

7.  p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.

Authors:  A G Casson; M Tammemagi; S Eskandarian; M Redston; J McLaughlin; H Ozcelik
Journal:  Mol Pathol       Date:  1998-04

Review 8.  Multimodality treatment of cancer arising from Barrett's epithelium.

Authors:  J A Roth
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

9.  Early p53 mutations in nondysplastic Barrett's tissue detected by the restriction site mutation (RSM) methodology.

Authors:  G J S Jenkins; S H Doak; A P Griffiths; N Tofazzal; V Shah; J N Baxter; J M Parry
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

10.  Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus.

Authors:  J R Stewart; S J Hoff; D H Johnson; M J Murray; D R Butler; C C Elkins; K W Sharp; W H Merrill; J L Sawyers
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.